The short answer: Workiva and Prova solve different problems and for most 300–1,500 emp companies are not substitutes. Workiva is the correctly-priced enterprise connected-reporting platform for 1,500+ emp public filers who need 10-K, 10-Q, 8-K, ESG, and SOX to live in one XBRL-tagged document system. Prova is the correctly-priced agent-native SOX specialist for 300–1,500 emp PE portcos and sub-$1B public microcaps whose core problem is ICFR testing cost, not financial-reporting-document fragmentation. Pricing diverges by roughly 4x at the SOX-only scope ($80K–$200K Workiva vs $12K–$60K Prova), PCAOB AS 2201 §.39 evidence paradigms diverge by generation (document-linking vs agent-reasoning), and implementation timelines diverge by 2–3x. The wrong pick burns $60K–$140K per year at the 650-emp scale and delays walkthrough-ready SOX by 8–16 weeks. The right pick is structural: your primary pain is the filer in Workiva, the controller in Prova.
This post is written for the Controller, Internal Audit Director, or CFO at a 300–1,500 emp company currently evaluating Workiva and Prova side-by-side — typically because AuditBoard's renewal quote forced the alternative evaluation and both names surfaced. The read is not objective: we are Prova and we have a point of view. But the read is honest in that we will explicitly name when Workiva is the right answer (it is for a specific scope), when stacking both is correct (rare but real), and when neither is right (most pre-IPO companies below 500 emp).
What does Workiva actually do?
Workiva is a connected-reporting platform. The core product is "Wdesk" — a document system where financial statements, footnotes, XBRL tags, ESG disclosures, and supporting workpapers live as linked objects that update together. A change in a source number propagates through every dependent document in the 10-K, the investor deck, the ESG disclosure, and the SOX narrative simultaneously. This is the engineering achievement that defines Workiva's moat and justifies the $4B+ market cap.
The SOX module sits inside that connected-reporting environment. Control narratives reference the financial-statement line items they support; walkthrough memos link to the specific journal entries or system-generated reports under test; deficiency memos update the quarterly disclosure controls cert automatically. This is elegant when a company is already filing 10-K and 10-Q and wants SOX documentation to flow into the same document lifecycle.
What Workiva is not: an agent-driven control-testing platform. Evidence collection is document-centric — workpapers, screenshots, attached system-generated reports linked to control records. The control-test workflow assumes a human auditor executing test procedures and attaching evidence, which is the traditional SOX paradigm pre-LLM. Workiva has added AI-assistive features through 2024–2026 (narrative generation, flux analysis summaries) but has not rebuilt the core testing workflow as agent-executed.
What does Prova actually do?
Prova is an agent-native SOX testing platform. A reasoning agent reads the control narrative for a specific control — say AC-04, "User access to the NetSuite production environment is reviewed quarterly by the control owner" — pulls the relevant evidence from source systems (NetSuite, Workday, Okta), reasons about whether the evidence supports the control operating effectively under PCAOB AS 2201 §.39 (evidence of control operation), produces a pass/fail determination, and signs the record with SHA-256 hashing plus the agent's preserved reasoning trace for reperformability under AS 2201 §.42 (nature, timing, and extent).
What Prova is not: a financial-reporting-document system. Prova produces SOX evidence records and a deficiency log that integrate into the 10-K disclosure controls narrative, but it does not tag XBRL, generate 10-Q drafts, or consolidate multi-period financial statements. That document-lifecycle is downstream of Prova and is handled by Workiva, your 10-K tagging service, or internal teams.
The deliberate scope choice is product focus. A department-head-tier ACV platform cannot credibly ship connected-reporting depth, XBRL, ESG, and agent-native SOX testing at the same time without either compromising all four or pricing like Workiva. The 300–1,500 emp tier buyer needs SOX done exceptionally, not reporting-plus-SOX done adequately.
Pricing side-by-side: what does each actually cost in 2026?
| Scope | Workiva ACV (2026) | Prova ACV (2026) | Delta |
|---|---|---|---|
| SOX module only | $80,000–$120,000 | $12,000–$60,000 | 2x–7x |
| SOX + Reporting (10-K/10-Q) | $150,000–$200,000 | N/A (not Prova's scope) | — |
| SOX + Reporting + ESG | $200,000–$350,000 | N/A (not Prova's scope) | — |
| Typical 650-emp PE portco spend | $150,000–$200,000 | $30,000–$50,000 | 4x |
| Typical 1,200-emp microcap spend | $200,000–$300,000 | $50,000–$80,000 | 4x |
Reading this table honestly: Workiva's pricing is not unfair. If a company is filing 10-K and 10-Q and consolidating four legal entities, the connected-reporting bundle replaces three separate vendors (SOX, filing agent, ESG) and the aggregate ACV is defensible. Where Workiva fails the 300–1,500 emp tier is when SOX is the primary pain and the filer-plus-ESG modules are unused feature surface.
Implementation timelines follow the same shape. Workiva SOX module implementation is 10–20 weeks — the connected-reporting environment requires mapping of every financial-statement account to narrative, every narrative to control, every control to evidence request. Prova implementation is 4–8 weeks because the control library, agent-testing harness, and evidence schema are pre-built and the work is integration authentication plus walkthrough dry-run with the external audit partner.
How does PCAOB AS 2201 evidence depth compare?
PCAOB AS 2201 establishes the evidence framework for tests of controls. The sections that matter are §.39 (evidence of control operation), §.42 (nature, timing, and extent of testing), and §.46–.50 (testing design and operating effectiveness). Both Workiva and Prova produce evidence that meets these requirements, but the evidence profile differs by generation.
Workiva evidence profile: document-linked workpapers with control-to-narrative-to-financial-statement-line-item traceability. The Big 4 walkthrough comfort is high because the format matches the auditor's existing mental model from AuditBoard and legacy SOX platforms. Evidence authenticity under AS 2201 §.39 is established by document version history; completeness under §.42 is established by the full control population being in the platform; reperformability under §.46 is established by the auditor re-executing the test against the attached evidence.
Prova evidence profile: agent-executed test records with preserved reasoning traces, SHA-256 hashed for integrity, pulled directly read-only from source systems. Evidence authenticity is established by cryptographic hash (the evidence cannot be altered after signing without invalidating the hash); completeness is established by continuous-population testing (100 percent of the population tested continuously, no sampling risk under §.46); reperformability is established by the auditor re-executing the same query against the same source system and confirming the same result, and also by inspecting the agent's reasoning trace to understand the interpretive steps. PCAOB inspection reports from late 2025 and 2026 specifically addressed agent-produced evidence with a cautiously accepting tone when these characteristics are demonstrable.
Where each profile wins: Workiva wins when external audit partner familiarity and multi-period consolidated-filing evidence is the primary risk vector. Prova wins when evidence volume matters (continuous population vs quarterly sample) and when the control population is large enough that manual sampling is the binding labor constraint.
Which control families can each platform actually test?
Workiva's SOX module tests control families through a human-auditor workflow. The auditor executes the test procedure (pulls access list, reconciles to HR termination list, documents findings), attaches evidence to the control record, and signs off. This works for every control family — high-frequency deterministic (access review, change management) and low-frequency judgmental (estimate review, journal entry review, complex revenue recognition under ASC 606) — because the human is the test executor and Workiva is the document system.
Prova tests control families through agent reasoning for high-confidence deterministic families and routes low-confidence judgmental families to human review. Specifically, agents handle user access review (role-entitlement alignment, orphan accounts, terminated-user access, privileged access use), change management (deployment approval, testing evidence, SoD between developer and deployer, emergency change documentation), ITGC baseline (backup completion, job scheduling, incident response evidence, vendor access logs), and entitlement-level SoD. These families represent 30–45 percent of a typical mid-market control population. Judgmental families (estimate review, management review, anti-fraud program review, complex revenue recognition under ASC 606) remain human-tested because the control requires accounting or investigative judgment the agent should not own — this is the honest architecture for PCAOB-acceptable continuous testing.
The practical implication: Workiva covers the full SOX population, but expensively. Prova covers 30–45 percent of the population agentically and surfaces the remainder for human judgment more efficiently, at roughly 1/4 the ACV. A 300–1,500 emp program should evaluate what percentage of its testing hours go to deterministic vs judgmental families before deciding which platform fits.
How do EU AI Act, DORA, CMMC 2.0, and SOC 2 TSC requirements land on each platform?
Regulatory-overlap surface is where mid-market programs bleed time in 2026. Most 300–1,500 emp companies running SOX also run SOC 2 Type II, and increasingly run DORA (EU financial), CMMC 2.0 (defense contractor), ISO 42001 (AI management), or state-level privacy (CCPA, SHIELD, Texas medical privacy).
Workiva regulatory-overlap profile: multi-framework support through the connected-reporting document system. The same control narrative can reference SOX, SOC 2 TSC CC6 (logical access) and CC7 (system operations), DORA Article 28 (ICT risk management) and Article 30 (ICT third-party risk), CMMC 2.0 Level 2 control families, and ISO 42001 AI management system controls. The evidence file sits once in the document system and the framework-tag mapping handles the rest. Strong for companies with heavy framework stacking.
Prova regulatory-overlap profile: SOX-primary with evidence export mappings for SOC 2 CC6/CC7/CC8, DORA Article 28 ITGC overlap, CMMC 2.0 access control families, and EU AI Act Article 13 (transparency) and Article 17 (record-keeping) where the continuous-testing agent itself falls within AI governance scope under EU AI Act general-purpose obligations effective August 2026. The evidence object is SOX-shaped; adjacent framework mapping is provided but is not the product's primary optimization target. A company running SOC 2 should stack Drata, Vanta, or Secureframe alongside Prova rather than expect Prova to cover SOC 2 attestation.
If your regulatory stack is SOX + SOC 2 + ISO 27001 + HIPAA + CMMC 2.0 + DORA all simultaneously, Workiva's document-system approach reduces the evidence-management overhead more than Prova's SOX-primary approach. If your regulatory stack is SOX-primary with SOC 2 as secondary, Prova + Drata/Vanta is cheaper and delivers deeper on each piece.
When does switching from Workiva to Prova make sense?
Four conditions suggest the switch is worth running.
First, SOX is your primary regulatory exposure and the reporting/ESG modules are underused. Count the Workiva modules you actually use. If SOX is 70 percent or more of the utilization and reporting/ESG is 30 percent or less, you are paying for surface area you do not need.
Second, your annual control-testing hours exceed 1,500 and the majority are on deterministic families. Access review, change management, and ITGC baseline testing together consume 60 percent of testing hours at a typical 650-emp PE portco. Moving these to agent testing returns 800–1,200 hours per year to the IA team.
Third, your external audit partner is willing to walk through agent-produced evidence before year-end commitment. This is the decisive variable. Run the dry-run. If the partner rejects the format, the Workiva stack remains the fallback.
Fourth, your ACV envelope requires it. If sponsor operating-partner review or audit committee budget review is forcing a $100K+ reduction in platform spend, Prova at $30K–$60K against Workiva at $150K–$250K is the structural answer. AuditBoard is the alternative at equivalent ACV to Workiva so the Workiva replacement quickly becomes a Prova or Hyperproof decision rather than a price negotiation with Workiva.
When does Workiva remain the right answer?
Three conditions keep Workiva structurally correct.
First, you are already filing 10-K and 10-Q and want the connected-reporting bundle. Replacing Workiva with a standalone SOX platform means the filer responsibilities still need a home. The aggregate cost of Workiva reporting + Prova SOX often exceeds Workiva bundled SOX + reporting.
Second, you have five or more frameworks in active testing and the document-system overlap reduces management overhead meaningfully. At six-plus frameworks the control-narrative-reuse pattern Workiva enables is genuine value.
Third, your Big 4 auditor has expressed a strong preference for document-linked workpaper formats and is not open to walking through agent-produced evidence. This posture has softened meaningfully through 2025–2026 but still exists at some partners, and the audit partner's preference is the decisive variable.
What about stacking both — Workiva + Prova together?
Rare but real. The pattern fits companies where reporting discipline is primary (Workiva keeps the 10-K, 10-Q, ESG lifecycle tight) and SOX testing cost is the bleed (Prova returns hours and reduces deterministic-control human labor). Combined ACV at a 900-emp pre-IPO is typically Workiva at $120K + Prova at $45K = $165K, vs Workiva-only at $180K–$220K with AuditBoard-equivalent SOX depth. The overlap risk is managed by scoping Workiva's SOX module to risk register and deficiency aggregation only, with evidence collection routed to Prova.
This is a real stack pattern for companies 12–18 months from S-1 where the IPO audit partner is Big 4 and wants connected-reporting quality plus agent-testing efficiency. For most 300–1,500 emp companies not in that specific window, the single-platform answer is correct.
A practical decision framework
Five questions separate the companies that should pick Workiva from those that should pick Prova from those that should stack both.
What percentage of my annual SOX scope is financial-reporting document lifecycle versus control testing? More than 40 percent reporting → Workiva. Less than 40 percent → Prova.
What is the feature utilization of my current platform? Below 40 percent → switch to the scope-matched alternative. Above 70 percent → stay.
What does my external audit partner accept? Ask them in a pre-commitment walkthrough. Their answer is the decisive variable.
What is my ACV envelope for the next 24 months? Below $60K → Prova or Hyperproof. $60K–$150K → scope-matched choice. Above $150K → Workiva becomes defensible if scope justifies.
What is my regulatory-framework count? Five-plus active frameworks with heavy document overlap → Workiva. SOX-primary with one or two adjacent frameworks → Prova + complementary SOC 2 tool.
The takeaway
Workiva and Prova are not replacements for each other at the structural level. Workiva is a connected-reporting platform with a SOX module. Prova is an agent-native SOX testing platform. The correct comparison is not "which is better" but "which fits my primary pain." Companies confusing the two end up over-paying (picking Workiva when SOX is 90 percent of scope) or under-delivering (picking Prova when consolidated filings and XBRL tagging are the binding constraint).
The honest posture: if you are reading this because a Workiva renewal quote is on your desk, run the utilization audit first. If SOX testing consumed more than 60 percent of your IA hours and the reporting module generated one 10-K draft in six months, the ACV is structurally misallocated. Switch to Prova or Hyperproof. If the reporting module generated the 10-K, 10-Q, proxy, and ESG disclosures and SOX was a clean 30 percent of the value, Workiva is correctly priced and the next question is whether AuditBoard is doing the SOX work better for the same money.
Either answer is defensible. Running the evaluation with real feature-utilization data is non-negotiable. Auto-renewing at $200K because nobody had 40 hours to audit the usage is the fiduciary failure mode in 2026.
If you are the Controller at a PE portfolio company, a pre-IPO 300–1,500 emp company, or a public microcap under $1B looking at the Workiva-vs-Prova decision, the next step is concrete: request a design partner slot and we will walk through a dry-run with your external audit partner before you commit. The AuditBoard alternatives comparison and continuous control testing primer cover the adjacent decisions.